Used in research as a selective α2-adrenergic receptor agonist, particularly in studies related to cardiovascular regulation and central nervous system activity. It has been investigated for its potential to modulate sympathetic nervous system output, which may contribute to blood pressure control and sedation in experimental models. Due to its structural properties, it serves as a pharmacological tool for probing imidazoline receptor pathways and related physiological responses. Not intended for therapeutic use in humans.